Acute myelogenous leukemia in pregnancy

Area of Science:

• Hematology
• Oncology
• Obstetrics

Background:

• Acute promyelocytic leukemia (APL) is a rare and aggressive subtype of leukemia.
• Pregnancy can complicate the diagnosis and treatment of hematologic malignancies.
• Managing APL during pregnancy requires careful consideration of maternal and fetal well-being.

Observation:

• A patient diagnosed with acute promyelocytic leukemia at 22 weeks gestation underwent chemotherapy.
• The patient achieved complete remission following treatment.
• Delivery occurred at 28 weeks gestation via cesarean section, resulting in a healthy male infant.

Findings:

• Successful chemotherapy treatment for acute promyelocytic leukemia during pregnancy is feasible.
• Current chemotherapy regimens can lead to complete remission in pregnant patients with APL.
• The treatment approach resulted in a healthy infant and a disease-free mother at 27 months post-diagnosis.

Implications:

• Chemotherapy for acute promyelocytic leukemia during pregnancy can be safe for both mother and fetus.
• This case highlights the possibility of achieving live births with current APL chemotherapy protocols.
• The findings suggest that risks associated with treating APL in pregnancy may be manageable.